Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
diagnostic tests
MedTech
Abbott inks $23B deal for Exact Sciences in cancer testing buy
Abbott has signed up to buy Exact Sciences in the largest diagnostics deal to date, acquiring the maker of the Cologuard at-home screening test.
Conor Hale
Nov 20, 2025 10:30am
LabCorp's diagnostics shine in Q3, but revenue forecast dims
Oct 28, 2025 10:15am
Labcorp to carry Roche's FDA-cleared Alzheimer's blood test
Oct 24, 2025 8:45am
Roche nabs FDA clearance for Alzheimer's biomarker blood test
Oct 14, 2025 11:12am
OraSure sees investor pressure, potential proxy fight: report
Sep 9, 2025 12:00pm
FDA formally kicks off medical device user fee negotiations
Aug 4, 2025 4:45pm
